Millennium Management’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Millennium Management’s Portfolio OCRX Stock Details OCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-320,000	Closed	-$672K	–	4078
2016 Q4	$672K	Sell	320,000 -196,343	-38%	-$458K	﹤0.01%	2496
2016 Q3	$1.36M	Hold	516,343	–	–	﹤0.01%	2125
2016 Q2	$981K	Sell	516,343 -14,788	-3%	-$38.9K	﹤0.01%	2179
2016 Q1	$1.56M	Sell	531,131 -2,663	-0.5%	-$7.6K	﹤0.01%	1937
2015 Q4	$1.67M	Sell	533,794 -15,251	-3%	-$52.1K	﹤0.01%	2038
2015 Q3	$1.74M	Buy	549,045 +32,470	+6%	+$125K	﹤0.01%	2009
2015 Q2	$1.96M	Sell	516,575 -17,891	-3%	-$68.6K	﹤0.01%	1943
2015 Q1	$2.52M	Buy	534,466 +104,428	+24%	+$602K	﹤0.01%	1805
2014 Q4	$2.74M	Sell	430,038 -57,276	-12%	-$335K	0.01%	1761
2014 Q3	$2.39M	Sell	487,314 -8,074	-2%	-$46.6K	0.01%	1752
2014 Q2	$3.79M	Buy	495,388 +92,724	+23%	+$739K	0.01%	1377
2014 Q1	$4.25M	Buy	+402,664	New	+$5.76M	0.01%	1292

Other funds holding OCRX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management's OCRX Position: Q1 2017 in Review

Millennium Management sold out of Ocera Therapeutics, Inc. (OCRX) in Q1 2017, closing a stake of 320,000 shares — an estimated $672K sold.

Millennium Management first reported a position in OCRX in Q1 2014 and held it in 12 quarters. The position peaked at $4.25M in Q1 2014. 26 funds tracked by Wall St. Rank hold OCRX as of Q1 2017.

Millennium Management reported no remaining Ocera Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
Millennium Management sold 320,000 Ocera Therapeutics, Inc. shares in Q1 2017, an estimated $672K.
Millennium Management first reported a position in Ocera Therapeutics, Inc. in Q1 2014 and held it in 12 quarters.
Millennium Management's Ocera Therapeutics, Inc. position peaked at $4.25M in Q1 2014.
26 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q1 2017.

Based on Millennium Management's 13F filing for Q1 2017, filed 15 May 2017.